Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;181(10):901-909.
doi: 10.1176/appi.ajp.20230329. Epub 2024 Sep 12.

Risk of Incident Psychosis and Mania With Prescription Amphetamines

Lauren V Moran  1 , Joseph P Skinner  1 , Ann K Shinn  1 , Kathryn Nielsen  1 , Vinod Rao  1 , S Trevor Taylor  1 , Talia R Cohen  1 , Cemre Erkol  1 , Jaisal Merchant  1 , Christin A Mujica  1 , Roy H Perlis  1 , Dost Ongur  1
Affiliations

Risk of Incident Psychosis and Mania With Prescription Amphetamines

Lauren V Moran et al. Am J Psychiatry. .

Abstract

Objective: Amphetamine prescribing has increased in the United States in recent years. Previous research identified an increased risk of incident psychosis with prescription amphetamines. The purpose of this study was to examine the impact of dose levels of prescription amphetamines on the risk of this rare but serious adverse outcome.

Methods: A case-control study using electronic health records was conducted to compare the odds of incident psychosis or mania with past-month exposure to prescription amphetamines. Case subjects were patients ages 16-35 hospitalized at McLean Hospital for incident psychosis or mania between 2005 and 2019. Control subjects were patients with an initial psychiatric hospitalization for other reasons, most commonly depression and/or anxiety. Amphetamine doses were converted to dextroamphetamine equivalents and divided into terciles. Secondary analyses evaluated the odds of psychosis or mania with methylphenidate use.

Results: Among 1,374 case subjects and 2,748 control subjects, the odds of psychosis and mania were increased for individuals with past-month prescription amphetamine use compared with no use (adjusted odds ratio=2.68, 95% CI=1.90-3.77). A dose-response relationship was observed; high doses of amphetamines (>30 mg dextroamphetamine equivalents) were associated with 5.28-fold increased odds of psychosis or mania. Past-month methylphenidate use was not associated with increased odds of psychosis or mania compared with no use (adjusted odds ratio=0.91, 95% CI=0.54-1.55).

Conclusions: Although use of hospitalized control subjects excludes individuals with less severe disease, leading to selection bias, the study results suggest that caution should be exercised when prescribing high doses of amphetamines, with regular screening for symptoms of psychosis or mania.

Keywords: Bipolar and Related Disorders; Schizophrenia Spectrum and Other Psychotic Disorders; Stimulants; Substance-Related and Addictive Disorders.

PubMed Disclaimer

Conflict of interest statement

Dr. Moran is employed by Sage Therapeutics. Dr. Perlis has served as a scientific adviser for Alkermes, Belle Artificial Intelligence, Burrage Capital, Circular Genomics, Genomind, Mila Health, Psy Therapeutics, Swan AI Studios, and Vault Health. Dr. Ongur has received honoraria from Boehringer Ingelheim, Guggenheim LLC, and Neumora for scientific presentations. The other authors report no financial relationships with commercial interests.

References

    1. Raman SR, Man KKC, Bahmanyar S, et al.: Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry 2018; 5:824–835 - PubMed
    1. Bykov K, He M, Gagne JJ: Trends in utilization of prescribed controlled substances in US commercially insured adults, 2004–2019. JAMA Intern Med 2020; 180:1006–1008 - PMC - PubMed
    1. Danielson ML, Bohm MK, Newsome K, et al.: Trends in stimulant prescription fills among commercially insured children and adults— United States, 2016–2021. MMWR Morb Mortal Wkly Rep 2023; 72: 327–332 - PMC - PubMed
    1. Schiffer WK, Volkow ND, Fowler JS, et al.: Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 2006; 59:243–251 - PubMed
    1. John CE, Jones SR: Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 2007; 52:1596–1605 - PMC - PubMed

MeSH terms